Antonio D’Alessio

NASH limits anti-tumour surveillance in immunotherapy-treated HCC

Dominik Pfister, Nicolás Gonzalo Núñez, Roser Pinyol et al. · Nature · 2021 · 1.2K citations · Full text

Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child‐Pugh A and B cirrhosis: A real‐world study

Antonio D’Alessio, Claudia Angela Maria Fulgenzi, Naoshi Nishida et al. · Hepatology · 2022 · 218 citations · Full text

T-cell exhaustion and residency dynamics inform clinical outcomes in hepatocellular carcinoma

Maryam Barsch, Henrike Salié, Alexandra Emilia Schlaak et al. · Journal of Hepatology · 2022 · 173 citations

T-cell Exhaustion, Hepatology, Residency Dynamics +11

Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis

Margherita Rimini, Lorenza Rimassa, Kazuomi Ueshima et al. · ESMO Open · 2022 · 124 citations · Full text

One-Trocar Transumbilical Laparoscopic-Assisted Appendectomy in Children: Our Experience

Antonio D’Alessio, Eugenia Piro, B. Tadini et al. · European Journal of Pediatric Surgery · 2002 · 111 citations